ALLKA Research | ALPMF | ALPMY | BMY | BMYMP | CELG.RT | DSKYF | DSNKY | GLAXF | GSK | MRK | MRK:CA | PFE | PFE:CA | SPY Merck Proves Why It’s Still A Top Pharma Pick ByMario Cazombo May 27, 2025
ALLKA Research | BMY | BMYMP | CELG.RT | CYTK | JPM | JPM:CA | JPM.PR.C | JPM.PR.D | JPM.PR.J | JPM.PR.K | JPM.PR.L | JPM.PR.M | MRK | MRK:CA | PFE | PFE:CA | RDY | TEVA | TEVJF Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence ByMario Cazombo May 27, 2025
ALLKA Research | AZN | AZNCF | BEIGF | BMY | BMYMP | CELG.RT | GILD | GILD:CA | GLAXF | GNFT | GNFTF | GSK | IPSEF | IPSEY | JNJ | JNJ:CA | MRK | MRK:CA | ONC Gilead Sciences’ Best Days May Be Ahead – Here’s Why ByMario Cazombo May 26, 2025
